Computational analysis demonstrates deep generative models design multi-specific compounds against target proteins, highlighting new avenues for polypharmacology.
In drug discovery, compounds with activity against more than one target protein resulting from target-specific interactions (multi-specificity) must be clearly distinguished from those with unde...
No takes yet. Share an insight, caveat, or question.
Jürgen Bajorath (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: